P

Inventor

CHAUDRY IMTIAZ A

US42 patents
⚠️ This page may combine multiple inventors who share the name “CHAUDRY IMTIAZ A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING CORP

30 patents
US6057307AMay 2, 2000

Use of mometasone furoate for treating airway passage and lung diseases

SCHERING CORP118 citations98
US5889015AMar 30, 1999

Use of mometasone furoate for treating lower airway passage and lung diseases

SCHERING CORP124 citations98
US5837699ANov 17, 1998

Use of mometasone furoate for treating upper airway passage diseases

SCHERING CORP125 citations98
US5474759ADec 12, 1995

Non-chlorofluorocarbon aerosol formulations

SCHERING CORP180 citations97
US5100675AMar 31, 1992

Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine

SCHERING CORP154 citations97
US4999189AMar 12, 1991

Sustained release oral suspensions

SCHERING CORP124 citations97
US4990535AFeb 5, 1991

Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

SCHERING CORP128 citations97
US6723713B2Apr 20, 2004

Use of mometasone furoate for treating upper airway diseases

SCHERING CORP26 citations96
US6677323B2Jan 13, 2004

Use of mometasone furoate for treating airway passage and lung diseases

SCHERING CORP33 citations96
US6677322B2Jan 13, 2004

Use of mometasone furoate for treating airway passage and lung diseases

SCHERING CORP36 citations96
US6365581B1Apr 2, 2002

Use of mometasone furoate for treating airway passage and lung diseases

SCHERING CORP34 citations96
US5679356AOct 21, 1997

Use of GM-CSF as a vaccine adjuvant

SCHERING CORP132 citations95
US5186930AFeb 16, 1993

Sustained release oral suspensions

SCHERING CORP70 citations95
US6416743B1Jul 9, 2002

Aerosol formulations of albuterol and 1,1,1,2-tetrafluoroethane

SCHERING CORP53 citations94
US6132758AOct 17, 2000

Stabilized antihistamine syrup

SCHERING CORP56 citations94
US4853218AAug 1, 1989

Zinc-protamine-alpha interferon complex

SCHERING CORP66 citations94
US6187765B1Feb 13, 2001

Mometasone furoate suspensions for nebulization

SCHERING CORP37 citations93
US6514520B2Feb 4, 2003

Stabilized antihistamine syrup

SCHERING CORP20 citations91
US6503482B1Jan 7, 2003

Non-chlorofluorocarbon aerosol formulations

SCHERING CORP36 citations91
US6051252AApr 18, 2000

Orally administrable solid dosage form

SCHERING CORP21 citations91
US5914128AJun 22, 1999

Orally administrable solid dosage form

SCHERING CORP18 citations91
US6068832AMay 30, 2000

Chlorofluorocarbon-free mometasone furoate aerosol formulations

SCHERING CORP44 citations90
US6949532B2Sep 27, 2005

Use of mometasone furoate for treating airway passage and lung diseases

SCHERING CORP8 citations82
US4851220AJul 25, 1989

Stable oleaginous gel

SCHERING CORP22 citations81
US6956030B2Oct 18, 2005

Use of mometasone furoate for treating upper airway diseases

SCHERING CORP6 citations73
US6337090B1Jan 8, 2002

Orally administrable solid ribavirin dosage forms and process for making them

SCHERING CORP11 citations72
US6335032B1Jan 1, 2002

Orally administrable solid dosage form

SCHERING CORP11 citations72
US5916594AJun 29, 1999

Process of making solid ribavirin dosage forms

SCHERING CORP13 citations72
US4328213AMay 4, 1982

Stable injectable labetalol formulation

SCHERING CORP10 citations66
US6939550B2Sep 6, 2005

Stabilized antihistamine syrup

SCHERING CORP3 citations61

DEY L P

3 patents

JPMORGAN CHASE BANK NA

3 patents

BANERJEE PARTHA S

3 patents

CHAUDRY IMTIAZ A

2 patents

MYLAN SPECIALTY L P

1 patent